Join us for Fullscript Forward, a free, live, virtual event featuring industry leaders driving the future of healthcare and the field of whole person care.
This presentation explores the pathophysiology of breast cancer risk in menopause and introduces the HuMap™, a non-invasive tool for assessing urinary hormones and their metabolites. This presentation will explore phase I and phase II estrogen metabolism, emphasizing the significance of urinary hormone and metabolite testing for uncovering an individual's unique metabolic function. Assessing estrogen metabolite imbalance is a reasonable first step to developing an effective risk reduction strategy for these patients.
Register here: |
| 11:05 AM PST |
Methylation is a fundamental biochemical process with far-reaching implications for human health. This presentation will offer an in-depth exploration of methylation, its clinical significance, and the impact of methylation imbalances on health outcomes.
Methylation is involved in cardiovascular health, detoxification, neurotransmitter synthesis, hormone metabolism, DNA expression, immune modulation and fetal development. Analyzing key methylation biomarkers provides valuable insight into human physiology. Plasma levels of methionine, s-Adenosyl methionine (SAM), s-Adenosyl homocysteine (SAH), homocysteine, cystathionine and cysteine provide a functional assessment of the methylation cycle. Attendees will walk away with an understating of these biomarkers, enhanced understanding of methylation dynamics and their impact on clinical outcomes.
Register here: |
| 12:00 PM PST |